This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Fob Synthesis, Inc., Georgia Tech Research Corporation, The United States of America as Represented by the Department of Health. Active years: 1997-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 7 
1 out of 2,196 
1 out of 1,217 
Years Active: 1997-2018
Title: Ewa Gruszecka-Kowalik: A Pioneer in Antibacterial Innovations
Introduction
Ewa Gruszecka-Kowalik is an accomplished inventor based in Atlanta, GA, known for her significant contributions to the field of antibacterial pharmaceuticals. With a remarkable track record of three patents to her name, her work primarily focuses on combating bacterial infections, particularly those caused by gram-negative bacteria.
Latest Patents
Among her latest patents is the groundbreaking invention of carbapenem antibacterials with gram-negative activity. This innovative work introduces β-methyl carbapenem compounds and pharmaceutical compositions that are instrumental in the treatment of bacterial infections. The invention outlines methods for effectively treating such infections by administering an effective amount of a carbapenem compound, or its salt and/or prodrug, to a host in need of treatment. This development showcases her commitment to enhancing healthcare solutions in the realm of infectious diseases.
Career Highlights
Throughout her career, Ewa has been affiliated with several notable organizations, including Fob Synthesis, Inc. and the United States of America, as represented by the Department of Health. These roles have allowed her to apply her expertise in pharmaceutical sciences and contribute to essential research in antibacterial agents.
Collaborations
Ewa has collaborated with respected professionals in her field, including Woo-Baeg Choi and Hyung-Yeul Joo. Their combined efforts have fostered advancements in the understanding and development of effective treatments against bacterial infections, highlighting the importance of teamwork in scientific innovation.
Conclusion
Ewa Gruszecka-Kowalik's work continues to make a significant impact on the medical community, particularly in the fight against bacterial infections. Her innovative inventions and dedication to research underscore the essential role that inventors play in advancing healthcare and improving patient outcomes. As the field of antibacterial treatment evolves, Ewa's contributions will be vital in shaping effective strategies for combating challenging infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile